Navigation Links
Plavix in Medical News

Study Upholds Stopping Plavix Use Before Surgery

Taken less than 5 days before operation leads to more bleeding, longer hospital stay, study finds MONDAY, Nov. 10 (HealthDay News) -- Someone who has taken the clot-preventing drug Plavix less than five days before having bypass surgery runs a higher risk of excess bleeding, is more li...

Blood-Thinner Plavix Works Harder in Smokers

But the finding certainly isn't any reason to start or continue smoking, researchers say MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates. Plavix (clopidogrel) is often given to hear...

First 90 Days After Stopping Plavix Most Dangerous

Study finds highest risk of adverse events for heart patients is in early period TUESDAY, Feb. 5 (HealthDay News) -- New research finds that the first three months after heart patients stop taking the clot-preventing drug Plavix are the most dangerous. "This is the first study to ma...

Gene Ups Risk for Those on Blood-Thinner Plavix

Younger patients with the mutation faced higher odds of heart attack, death, study found MONDAY, Dec. 22 (HealthDay News) -- A gene variation can make younger heart attack patients more prone to another heart attack, death or other heart problems if they receive the anti-clotting drug ...

Generic Competitor for Plavix Blocked in US

Never mind Sicko. Everyday expressions of outrage over the soaring healthcare costs dont seem to matter either for US judges. A Canadian company's cheap generic version of the blood thinner Plavix has been blocked from the U.S. market until at least 2011. U.S. District Judge Sidney H. Stein said T...

Doubling Plavix Dose Recommended Before Angioplasty

Never mind the side-effects of Plavix, (generic name clopidogrel), the popular anti-blood-clotting drug . A new study reveals doubling the current recommended dose of Plavix to angioplasty patients, from 300 milligrams to 600, cut the combined risk of heart attack and cardiac death by half....

Sanofi-Aventis Allows Thais To Make Plavix

The generic version of Plavix, the heart disease medicine of Sanofi-Aventis will be made indigenously in Thailand. This was announced by the pharma company on Tuesday.// As per the offer made by Sanofa-Aventis, the health ministry has approved plans to buy or make imitated version of the drug. ...

Accumetrics' VerifyNow(R) P2Y12 Test Provides Physicians With Information to Assess a Patient's Response to Newly-Approved Prasugrel (Effient(R))

...trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. plavix is a registered trademark of Sanofi-Aventis. Effient is a registered trademark of Lilly-Daiichi Sankyo. CONTACT: Jules Abraham Li...

Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)

... non-fatal heart attack or non-fatal stroke versus plavix taken with aspirin. This benefit was driven predo...art attacks. The benefit of Effient compared with plavix was seen as early as three days and continued over...is) in patients treated with Effient compared with plavix (a relative risk reduction of approximately 50 per...

Portola Pharmaceuticals to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update

...and chronic care markets. The company has a global development and commercialization agreement with Novartis for elinogrel, a potential competitor for plavix (clopidogrel). Portola also has proprietary pipeline programs focused on the discovery and development of novel, specific Syk and JAK inhibitors...
Plavix in Medical Technology

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

...rademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. plavix is a registered trademark of sanofi-aventis. CONTACT: Jules Abraham Lippert/Heilshorn & Associates 212-838-3777 jabrah...

Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention

...ost often to treat and prevent thrombosis in arteries. The worldwide market for anti-platelet drugs in 2008 is estimated at over $8 billion driven by plavix and is expected to grow to over $14 billion by 2020. About Portola Pharmaceuticals, Inc. Portola Pharmaceuticals develops innovative t...

Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application

...red in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. P-LLY plavix is a registered trademark of Sanofi Aventis Corp. This press release contains certain forward-looking statements about the potential of the investiga...

Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168

...06) will characterize the pharmacodynamic effects of CGT-2168 compared with plavix and will expand earlier findings of comparability. "In a previous clinical ...y available omeprazole significantly decreases the antiplatelet activity of plavix when the two medicines are co-administered. "This finding is consistent wit...

Micell Technologies Presents Data on Novel Drug-Eluting Stents

...s including inherently thrombogenic polymers, residual drugs and patient compliance issues related to the necessary oral anti-platelet therapy such as plavix and aspirin, required of patients who receive drug-eluting stents. "Our technology provides an opportunity for optimal design of therapeutic profile...
Plavix in Biological Technology

Sanofi-aventis Announces Second Quarter 2009 Results

...econd half of 2009. Worldwide presence of plavix ((R)) /Iscover ((R)) Second-quarter sales of plavix ((R)) were up 9.6%, driven by a good performance...n Europe, which represents less than 25% of sales, plavix ((R)) saw a slight decline (of 3.2%) due to compe...

Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg

...rademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. plavix is a registered trademark of sanofi-aventis. A b ou t A A Z AAZ-LMB is a French company specializing in In Vitro Diagnostic Products...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

...nd Daiichi Sankyo's filings with the Tokyo Stock Exchange. Daiichi Sankyo and Lilly undertake no duty to update forward-looking statements. plavix (R) and Iscover (R) are registered trademarks of sanofi-aventis. P-LLY (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ...

European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

... treating ACS." In a large Phase III study, prasugrel was superior to plavix (R) /Iscover (R) (clopidogrel) in reducing the risk of suffering major car...nd Lilly undertake no duty to u p date forward-looking statements. plavix (R) /Iscover (R) are registered trademarks of sa n ofi-aventis. ...

Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics

...trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. plavix is a registered trademark of Sanofi-Aventis. CONTACT: Jules Abraham Lippert Heilshorn & Associates 212-8...

deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke

...ications for the prevention of recurrent stroke, because most patients who have suffered a cryptogenic or large vessel event are discharged and put on plavix or aspirin, which have little impact in preventing AF. Testing all of their stroke and TIA patients with deCODE AF(TM), doctors can identify those who...

Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company

... vs. 2008 2007 Change 2008 2007 Change 2007 Three Months Ended March 31, Pharmaceuticals Cardiovascular plavix $1,308 $938 39% $1,139 $787 45% 78% Avapro/Avalide 305 270 13% 174 163 7% (7)% Pravac...

FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)

...ntiplatelet PLAVIX(R) (clopidogrel bisulfate). The plavix 300mg tablet will facilitate the use of the FDA ap... Medicines Evaluation Agency (EMEA) review. About plavix plavix is a prescription antiplatelet medicine taken once...

Big Pharma's continued hunger and search for new products

...tical Products Product/Company Disease Area Sales ($billions) % Growth 1. Lipitor (Pfizer) Cholesterol Reduction $12.9 +6% 2. plavix (Bristol-Myers Squibb) Anti-coagulant $5.9 +16% 3. Nexium (AstraZeneca) Gastrointestinal Disorders $5.7 + 17% 4. Seretide/Advair (Glaxo Sm...
Other Tags
(Date:8/29/2015)... ... 2015 , ... On September 30, 2015, the Career and Transfer Center (CTC) ... Maricopa Community Colleges , will be hosting a Job Expo to provide a ... opportunities. , The Expo has expanded to much more than just a typical job ...
(Date:8/29/2015)... ... August 29, 2015 , ... It can be uncomfortable to ... urine and sweat. "In order to prevent these problems, I conceived of my ... ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It improves comfort ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... Next weekend ... of summer (which astronomically, officially ends on September 22nd this year). For IT security ... security hangovers linger on which could prove far more costly than a simple headache. ...
(Date:8/29/2015)... ... 2015 , ... The popular television program VOICES IN AMERICA, hosted by legendary ... be devoting an entire short segment to the subject of diabetes. Diabetes is a ... a daily basis, but recent advancements in medical science may prove to be a ...
(Date:8/28/2015)... ... August 28, 2015 , ... An online provider of CPAP machines, masks, ... of CPAP equipment more affordable by offering shipping at no cost to you, directly ... and orders of any size. My Cpap Store is located in Las Vegas, Nevada. ...
Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
(Date:8/5/2015)... , August 5, 2015 Transparency ... "Facial Recognition Market - Global Industry Analysis, Size, Share, ... market for facial recognition is forecast to reach US$ ... increased demand for surveillance systems by civil and government ... of crimes and terrorist activities across the globe that ...
(Date:8/4/2015)... AMRI ) today reported financial and operating results for the second ... Second quarter contract revenue of $ 85.2 million, ... margins of 26 % , Second quarter ... from royalties in the current quarter , Operating ... pleased to present another strong financial quarter, with all our divisions ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
Other Contents